183 related articles for article (PubMed ID: 19913014)
1. Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice.
Beahrs T; Tanzer L; Sanders VM; Jones KJ
Exp Neurol; 2010 Jan; 221(1):225-30. PubMed ID: 19913014
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice.
Serpe CJ; Byram SC; Sanders VM; Jones KJ
Brain Behav Immun; 2005 Mar; 19(2):173-80. PubMed ID: 15664790
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice.
Serpe CJ; Sanders VM; Jones KJ
J Neurosci Res; 2000 Oct; 62(2):273-8. PubMed ID: 11020219
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
Deboy CA; Xin J; Byram SC; Serpe CJ; Sanders VM; Jones KJ
Exp Neurol; 2006 Sep; 201(1):212-24. PubMed ID: 16806176
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection.
Serpe CJ; Coers S; Sanders VM; Jones KJ
Brain Behav Immun; 2003 Oct; 17(5):393-402. PubMed ID: 12946661
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells do not mediate facial motoneuron survival after facial nerve transection.
Byram SC; Serpe CJ; Pruett SB; Sanders VM; Jones KJ
Brain Behav Immun; 2003 Dec; 17(6):417-25. PubMed ID: 14583233
[TBL] [Abstract][Full Text] [Related]
7. Identification of a resilient mouse facial motoneuron population following target disconnection by injury or disease.
Setter DO; Haulcomb MM; Beahrs T; Meadows RM; Schartz ND; Custer SK; Sanders VM; Jones KJ
Restor Neurol Neurosci; 2018; 36(3):417-422. PubMed ID: 29614705
[TBL] [Abstract][Full Text] [Related]
8. Impact of peripheral immune status on central molecular responses to facial nerve axotomy.
Setter DO; Runge EM; Schartz ND; Kennedy FM; Brown BL; McMillan KP; Miller WM; Shah KM; Haulcomb MM; Sanders VM; Jones KJ
Brain Behav Immun; 2018 Feb; 68():98-110. PubMed ID: 29030217
[TBL] [Abstract][Full Text] [Related]
9. CD4(+) T cell-mediated facial motoneuron survival after injury: Distribution pattern of cell death and rescue throughout the extent of the facial motor nucleus.
Canh MY; Serpe CJ; Sanders V; Jones KJ
J Neuroimmunol; 2006 Dec; 181(1-2):93-9. PubMed ID: 17045343
[TBL] [Abstract][Full Text] [Related]
10. Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: effect of genetic background and the RAG2 gene.
Ha GK; Huang Z; Streit WJ; Petitto JM
J Neuroimmunol; 2006 Mar; 172(1-2):1-8. PubMed ID: 16376435
[TBL] [Abstract][Full Text] [Related]
11. Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
Xin J; Wainwright DA; Serpe CJ; Sanders VM; Jones KJ
Brain Behav Immun; 2008 May; 22(4):528-37. PubMed ID: 18024079
[TBL] [Abstract][Full Text] [Related]
12. Immunodeficiency impairs re-injury induced reversal of neuronal atrophy: relation to T cell subsets and microglia.
Ha GK; Huang Z; Parikh R; Pastrana M; Petitto JM
Exp Neurol; 2007 Nov; 208(1):92-9. PubMed ID: 17761165
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.
Runge EM; Iyer AK; Setter DO; Kennedy FM; Sanders VM; Jones KJ
J Neuroinflammation; 2020 Apr; 17(1):121. PubMed ID: 32303238
[TBL] [Abstract][Full Text] [Related]
14. Immune cell-mediated neuroprotection is independent of estrogen action through estrogen receptor-alpha.
Xin J; Fargo KN; Tanzer L; Sanders VM; Jones KJ
Metab Brain Dis; 2012 Mar; 27(1):23-8. PubMed ID: 21975535
[TBL] [Abstract][Full Text] [Related]
15. T cell memory in the injured facial motor nucleus: relation to functional recovery following facial nerve crush.
Ha GK; Pastrana M; Huang Z; Petitto JM
Neurosci Lett; 2008 Oct; 443(3):150-4. PubMed ID: 18687384
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice.
Serpe CJ; Kohm AP; Huppenbauer CB; Sanders VM; Jones KJ
J Neurosci; 1999 Jun; 19(11):RC7. PubMed ID: 10341268
[TBL] [Abstract][Full Text] [Related]
17. IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy.
Huang Z; Ha GK; Petitto JM
Neurosci Lett; 2007 May; 417(2):160-4. PubMed ID: 17418948
[TBL] [Abstract][Full Text] [Related]
18. SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.
Mesnard-Hoaglin NA; Xin J; Haulcomb MM; Batka RJ; Sanders VM; Jones KJ
Brain Behav Immun; 2014 Aug; 40():55-60. PubMed ID: 24911596
[TBL] [Abstract][Full Text] [Related]
19. Impairment of axotomy-induced pituitary adenylyl cyclase-activating peptide gene expression in T helper 2 lymphocyte-deficient mice.
Armstrong BD; Abad C; Chhith S; Cheung-Lau G; Hajji OE; Coute AC; Ngo DH; Waschek JA
Neuroreport; 2006 Feb; 17(3):309-12. PubMed ID: 16462603
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells and CD1-restricted NKT cells do not mediate facial motoneuron survival after axotomy.
DeBoy CA; Byram SC; Serpe CJ; Wisuri D; Sanders VM; Jones KJ
J Neuroimmunol; 2006 Jul; 176(1-2):34-8. PubMed ID: 16766044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
